Silvia Antolin Novoa (Silvia Antolín, Silvia Antolín Novoa)

Publication Activity (10 Years)

Years Active: 2021-2023
Publications (10 Years): 4

Top Topics

Positive Breast Cancer

Magnetic Resonance

Radiation Therapy

Epidermal Growth Factor Receptor

Top Venues

Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico

Journal of foot and ankle research

Virchows Archiv : an international journal of pathology

This page only lists publications with an associated author ORCID identifier.

Publications

Francisco Ayala, Silvia Antolin Novoa, Joaquín Gavilá, Lucía González Cortijo, Fernando Henao, María Teresa Martínez Martínez, Cristina Morales Estévez, Agostina Stradella, María Jesús Vidal Losada, Eva Ciruelos Gil
SEOM-GEICAM-SOLTI clinical guidelines for early-stage breast cancer (2022). Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico (2023)
Raquel Veiga-Seijo, Sonia Pertega-Diaz, Maria Eva Perez-Lopez, Lourdes Calvo Martinez, Silvia Antolin Novoa, Cristina González-Martin
Foot health and quality of life in women with breast cancer undergoing chemotherapy: a cross-sectional study. Journal of foot and ankle research 16 (1) (2023)
Francisco Ayala, Silvia Antolin Novoa, Joaquín Gavilá, Lucía González Cortijo, Fernando Henao, María Teresa Martínez Martínez, Cristina Morales Estévez, Agostina Stradella, María Jesús Vidal Losada, Eva Ciruelos Gil
Correction: SEOM-GEICAM-SOLTI clinical guidelines for early-stage breast cancer (2022). Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico (2023)
Silvia Antolin Novoa, Lucía García-Caballero, Cristina Reboredo, Aurea Molina, Joaquín Mosquera, Ángel Vázquez-Boquete, Rosalía Gallego, Mari Paz Santiago, Ángel Concha, Maria Eva Perez-Lopez, Lourdes Calvo Martinez, Tomás García-Caballero
Is there a correlation between HER2 gene amplification level and response to neoadjuvant treatment with trastuzumab and chemotherapy in HER2-positive breast cancer? Virchows Archiv : an international journal of pathology 479 (4) (2021)